Benelux Morning Notes

AEGON: US Life Brighthouse sale to PE a (slow) trend. Athora: Peer of ASR, NN, 1H25 results. Strong OCG growth, lower Solvency. EVS: Peer Evertz 1Q26 results

ODDO BHF SECURITIES LARGE CAPS MORNING NEWS 09/10/2025

ODDO BHF SECURITIES LARGE CAPS MORNING NEWS 10/09/2025

Aegon : Sale part a.s.r. logical, est. SBB € 1bn in FY26, no impact on...

Benelux Morning Notes

Azelis: Highlights ING Benelux Conference London. Barco: Highlights ING Benelux Conference London. Kinepolis: Highlights ING Benelux Conference London. Melexis: Highlights ING Benelux Conference London. ABN AMRO: Dutch State reducing stake to 20%. ASML: x Mistral, a bet on A.I.. Kinepolis: Cineplex August 2025 box office revenue at 87% of 2019 level, down 27% YoY

Morning Notes : KIN BB, SOF BB, XFAB FP, AZE BB

: KIN BB, SOF BB, XFAB FP, AZE BB

Kinepolis Group Keep The Faith, they Wanna Be Startin' Somethin' in M&...

Investors should Keep The Faith as Kinepolis Group showed resilience in 1H25, rebounding from a weak start with strong 2Q visitor growth and rising profitability, supported by premium formats. While the delay of the Michael biopic (originally planed for 3Q) deprived cinemas of a potential blockbuster boost, Kinepolis' management remains confident. Despite a challenging August and an uncertain 3Q outlook, a strong 4Q and FY26 pipeline offers hope for recovery. In the meantime, Kinepolis continues...

Benelux Morning Notes

Ageas: Highlights ING Benelux Conference London. Alfen: Highlights from ING Benelux Conference London. Arcadis: Highlights ING Benelux Conference London. ASR: Highlights ING Benelux Conference London. BAM: Highlights ING Benelux Conference London. Basic-Fit: Highlights ING Benelux Conference London. CTP: Highlights from ING Benelux Conference London. DEME Group: Highlights ING Benelux Conference London. Fugro: Highlights ING Benelux Conference London. Heijmans: Highlights ING Bene...

Benelux Morning Notes

Avantium: Expanded rights. CVC Capital Partners: 1H25 results. D'Ieteren: 1H25 5% miss, guidance reiterated on confidence for a much better 2H25. Kinepolis: August 2025 box office revenue/ attendance in US/Canada, France down >20%

Dynamic Top Pick List Update September: Adding AB InBev and Exor

In this September update we added 2 stocks to the KBC Securities Dynamic Top Pick List : We added AB InBev after the share price weakened post-2Q results. ABI's 2Q volumes fell 1.9% organically, below expectations, mainly due to a 9% drop in Brazil where a price hike led to temporary market share loss. However, strong revenue per hl growth (+4.9%) drove a 6.5% organic EBITDA increase, with 1H growth at +7.2%, near the top of FY guidance (+4–8%). AB InBev, the world's largest brewer, generates ...

Benelux Morning Notes

AEGON & ASR: placing a 6% stake in ASR, happy family. Events Calendar

Kinepolis/More popcorn, more EBITDA/BUY

We up our EPS up 2%-1%, our target price remains unchanged. Kinepolis reported a strong 1H, on better operating leverage, higher ticket and ITS, slightly higher visitors while net debt was in line. We slightly cut our visitors estimates on a more prudent 3Q, but this is more than offset by higher spend per visitor and margins. The stock underperforms 22% YTD, as a too-bullish consensus was adjusting to a weaker attendance. We think the case is worth revisiting. The pure standalone recovery story...

Morning Notes : ACKB BB, HAL NA, NEXTA BB, RECT BB, RET BB, UCB BB, BT...

: ACKB BB, HAL NA, NEXTA BB, RECT BB, RET BB, UCB BB, BTLS BB, ECMPA NA

Biotalys EPA's review on Evoca in 4Q rather than by end September

In an update on the regulatory approval procedure in the US of Evoca, its first protein-based biocontrol product, Biotalys has received further guidance from EPA, the U.S. Environmental Protection Agency on the regulatory review of Evoca. The EPA has confirmed that the scientific review of the dossier is progressing, and that all the requests for additional information have been addressed. While the agency continues to work diligently on the review, Biotalys now expects the final steps of the re...

ODDO BHF SECURITIES LARGE CAPS MORNING NEWS 08/26/2025

ODDO BHF SECURITIES LARGE CAPS MORNING NEWS 26/08/2025

Aegon : US listing and large a.s.r. stake of 36% of company gives it m...

Alfen/Near-term outlook remains clouded/HOLD

Alfen reported broadly in line 1H25 results and maintained its 2025 outlook but lowered its 2026 revenue growth and adjusted its EBITDA margin guidance. As a result, we cut our FY26F revenue estimate by c.4% and our FY26F EBITDA estimate by around 16%. Alfen's Smart Grid division reported rather weak production volumes in 2Q25 and a very low quarterly gross margin, which increased the overall risk profile of the company. The Smart Grid division has the most attractive fundamental characteristics...

Deceuninck/1H25: weak performance in Turkey/HOLD

We reiterate our HOLD on Deceuninck, but lower our target price to €2.3, from €2.5, following the group's 1H25 results. We note that the profitability in Turkey has disappointed, following a double-digit drop in sales, materially below the Street's expectations. Turkey accounted for >50% of group Adj. EBITDA last year. We expect high interest rates and inflation to continue to negatively affect the group's operating profit, but also its financial expenses due to its hedging policy in the country...

Tessenderlo Feedback 1H results conference call

Below are the highlights from the conference call. Tessenderlo's 1H results positively surprised, with adj EBITDA up 8% y/y to 163.4m, which was 19% better than our forecast and 12% above consensus. The company reiterated its broad FY25 guidance range, with consensus currently at the midpoint of the range whilst KBCS estimates are at the low end of the guidance range (and will be upped somewhat). The company is using its solid balance sheet and FCF to buy back own shares. We consider valuation t...